Trump Orders Federal Rescheduling To Expand Cannabis Research
Tap title to read story
Washington, President Donald Trump signed an executive order Thursday directing federal agencies to expedite reclassification of cannabis from Schedule I to Schedule III under the Controlled Substances Act. Officials said the change recognizes medical use and will ease research barriers, banking access, and tax treatment such as 280E relief. State researchers and attorneys general offered mixed reactions, noting potential benefits for clinical studies and continued regulatory constraints, heightened federal oversight. Cannabis companies and payment firms welcomed the move, citing improved operations and investment prospects. The executive order does not legalize recreational use. Based on 6 articles reviewed and supporting research.
More context
Timeline
- 1. November 12, 2025 — Federal clarification issued on hemp-derived intoxicants.
- 2. December 18, 2025 — President signs executive order directing expedited rescheduling to Schedule III.
- 3. December 18, 2025 — Corporations (FLUENT, POSaBIT) issue supportive press releases.
- 4. December 18–19, 2025 — Local researchers and state officials comment on research opportunities and regulatory limits.
- 5. Post-signature — Attorneys general and legal actors indicate potential challenges and extended administrative procedure.
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
